Compound
Tirzepatide (GLP-2)
Tirzepatide (GLP-2) is supplied by PX1 Research as a lyophilized research-grade dual GIP/GLP-1 receptor agonist at ≥99% HPLC purity, for laboratory use only.
Overview
Tirzepatide (GLP-2) is supplied by PX1 Research as a research-grade lyophilized material classified as a dual GIP/GLP-1 receptor agonist. It is characterized for laboratory investigation in incretin and metabolic research, and every vial is traceable to a lot record with analytical data behind it.
Analytical profile
| Property | Value |
|---|---|
| Classification | dual GIP/GLP-1 receptor agonist |
| Other designations | LY3298176 |
| Molecular weight | 4813 g/mol |
| Reported half-life | ~5 days |
| Supplied format | Lyophilized solid, 10 mg / 15 mg / 30 mg / 60 mg |
| Purity specification | ≥99% by HPLC, identity confirmed by LC-MS |
| Research focus | incretin and metabolic research |
Handling and reconstitution
Sealed lyophilized vials are stable in ambient transit and should be held cool, dry and dark on arrival; −20 °C is preferred for long-term storage. A typical working preparation for this vial size is 10 mg + 2 mL = 5 mg/mL. Direct the diluent stream down the inside wall of the vial rather than onto the cake, swirl gently rather than shaking, label the vial with concentration and date, and hold reconstituted material at 2–8 °C. Use the peptide calculator to convert milligrams to U-100 units.
Amounts reported in published laboratory literature
| Arm | Amount | Cadence |
|---|---|---|
| Initiation | 2.5 mg | weekly × 4 |
| Step 1 | 5 mg | weekly × 4 |
| Step 2 | 7.5 mg | weekly × 4 |
| Step 3 | 10 mg | weekly × 4 |
| Maximal arms | 15 mg | weekly |
These figures are transcribed from published in-vitro and pre-clinical literature for reference. They are not protocols and are not instructions for use.
Related references
- cagrilintide
Documentation supplied by PX1 Research
Every PX1 lot ships with HPLC purity, LC-MS identity confirmation, residual solvent, moisture (Karl Fischer), sterility and endotoxin data. Lot records are published at /coa and /endotoxin-reports. Synthesis, purification, lyophilization and vial fill are performed in U.S. facilities — see /manufacturing-process.
Research use only. PX1 Research supplies compounds for laboratory and in-vitro research. Nothing on this page is medical advice, a dosing recommendation, or an offer for human or veterinary use.